{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T20:21:44Z","timestamp":1773001304726,"version":"3.50.1"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"DOI":"10.3389\/fbioe.2020.00916","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T15:26:47Z","timestamp":1596122807000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":70,"title":["Prospects for RNAi Therapy of COVID-19"],"prefix":"10.3389","volume":"8","author":[{"given":"Hasan","family":"Uluda\u011f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kylie","family":"Parent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza Montazeri","family":"Aliabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azita","family":"Haddadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.antiviral.2006.10.008","article-title":"Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a\/7b, 3a\/3b and S.","volume":"73","author":"Akerstr\u00f6m","year":"2007","journal-title":"Antiviral Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/cgt.2013.8","article-title":"Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells.","volume":"20","author":"Aliabadi","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"B3","year":"2020","journal-title":"Vir and Alnylam Expand Collaboration to Advance Rnai Therapeutics for the Treatment of Coronavirus Infection, Including Covid-19."},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1177\/135965350601100803","article-title":"Indomethacin has a potent antiviral activity against SARS coronavirus.","volume":"11","author":"Amici","year":"2006","journal-title":"Antiviral Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/cts.12797","article-title":"Hydroxychloroquine for treatment of SARS-CoV-2 Infection? Improving our confidence in a model-based approach to dose selection.","volume":"13","author":"Arnold","year":"2020","journal-title":"Clin. Transl. Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"F443","DOI":"10.1136\/archdischild-2018-315413","article-title":"Understanding the principle biophysics concepts of pulmonary surfactant in health and disease.","volume":"104","author":"Autilio","year":"2019","journal-title":"Arch. Dis. Child. Fetal. Neonatal. Ed."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.4161\/auto.21229","article-title":"Unconventional roles of nonlipidated LC3 in ERAD tuning and coronavirus infection.","volume":"8","author":"Bernasconi","year":"2012","journal-title":"Autophagy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0168-3659(03)00359-6","article-title":"Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery.","volume":"93","author":"Bhavane","year":"2003","journal-title":"J. Control Rel."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01805-2016","article-title":"The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease.","volume":"50","author":"Burgstaller","year":"2017","journal-title":"Eur. Respir. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/molecules16021544","article-title":"Identification and characterization of three novel small interference RNAs that effectively down-regulate the isolated nucleocapsid gene expression of SARS coronavirus.","volume":"16","author":"Cao","year":"2011","journal-title":"Molecules"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1128\/jvi.01281-09","article-title":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB\/c mice: CD4+ T cells are important in control of SARS-CoV infection.","volume":"84","author":"Chen","year":"2010","journal-title":"J. Virol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.04.002","article-title":"Genomics functional analysis and drug screening of SARS-CoV-2.","author":"Chen","year":"2020","journal-title":"Genes Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12250-020-00221-6","article-title":"Computational identification of small interfering RNA targets in SARS-CoV-2.","volume":"35","author":"Chen","year":"2020","journal-title":"Virol. Sin"},{"key":"B14","doi-asserted-by":"publisher","first-page":"7819","DOI":"10.1128\/jvi.79.12.7819-7826.2005","article-title":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis.","volume":"79","author":"Cheung","year":"2005","journal-title":"J. Virol."},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8020309","article-title":"Vaccines against coronaviruses: the state of the Art.","volume":"8","author":"Conte","year":"2020","journal-title":"Vaccines"},{"key":"B16","doi-asserted-by":"publisher","first-page":"9029","DOI":"10.1128\/jvi.01331-15","article-title":"The nucleocapsid protein of Coronaviruses acts as a viral suppressor of RNA silencing in mammalian cells.","volume":"89","author":"Cui","year":"2015","journal-title":"J. Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1586\/14787210.4.2.291","article-title":"Potential antivirals and antiviral strategies against SARS coronavirus infections.","volume":"4","author":"De Clercq","year":"2006","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007587","article-title":"Host factor prioritization for pan-viral genetic perturbation screens using random intercept models and network propagation.","volume":"16","author":"Dirmeier","year":"2020","journal-title":"PLoS Comput. Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/ddr.21571","article-title":"The potential of siRNA based drug delivery in respiratory disorders: recent advances and progress.","volume":"80","author":"Dua","year":"2019","journal-title":"Drug Dev. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/bf01314299","article-title":"Significance of lysosomes in the morphogenesis of coronaviruses.","volume":"79","author":"Ducatelle","year":"1984","journal-title":"Arch. Virol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.19-0433","article-title":"Alveolar wars: the rise of in vitro models to understand human lung alveolar maintenance, regeneration, and disease.","author":"Evans","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00705-019-04470-z","article-title":"miR-142a-3p promotes the proliferation of porcine hemagglutinating encephalomyelitis virus by targeting Rab3a.","volume":"165","author":"Fan","year":"2020","journal-title":"Arch. Virol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/jmv.20953","article-title":"The membrane protein of SARS\u2212CoV suppresses NF-\u03baB activation.","volume":"79","author":"Fang","year":"2007","journal-title":"J. Med. Virol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105960","article-title":"Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.","volume":"55","author":"Fantini","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B25","first-page":"43","article-title":"Seasonal influenza vaccines.","volume":"333","author":"Fiore","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1128\/jvi.01662-09","article-title":"The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death.","volume":"84","author":"Freundt","year":"2010","journal-title":"J. Virol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119338","article-title":"Developing spray-freeze-dried particles containing a hyaluronic acid-coated liposome\u2013protamine\u2013DNA complex for pulmonary inhalation.","volume":"583","author":"Fukushige","year":"2020","journal-title":"Int. J. Pharmaceut."},{"key":"B28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jconrel.2018.10.012","article-title":"Pulmonary surfactant and drug delivery: focusing on the role of surfactant proteins.","volume":"291","author":"Guagliardo","year":"2018","journal-title":"J. Control Rel."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.virusres.2007.01.022","article-title":"Pathogenetic mechanisms of severe acute respiratory syndrome.","volume":"133","author":"Guo","year":"2008","journal-title":"Virus Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0014-5793(02)03640-2","article-title":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme.","volume":"532","author":"Harmer","year":"2002","journal-title":"FEBS Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1001\/jama.290.20.2665","article-title":"Inhibition of SARS-associated coronavirus infection and replication by RNA interference.","volume":"290","author":"He","year":"2003","journal-title":"JAMA"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.febslet.2006.03.066","article-title":"Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus.","volume":"580","author":"He","year":"2006","journal-title":"FEBS Lett."},{"key":"B34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/jmcb\/mjaa015","article-title":"Combating COVID-19 with chloroquine.","volume":"12","author":"Hong","year":"2020","journal-title":"J. Mol. Cell Biol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00105","article-title":"MiR-10a-5p-mediated syndecan 1 suppression restricts porcine hemagglutinating encephalomyelitis virus replication.","volume":"11","author":"Hu","year":"2020","journal-title":"Front. Microbiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"7221","DOI":"10.1128\/jvi.00440-09","article-title":"Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein.","volume":"83","author":"Hurst","year":"2009","journal-title":"J. Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7212","DOI":"10.1128\/jvi.02406-07","article-title":"Severe acute respiratory syndrome coronavirus protein 6 accelerates murine hepatitis virus infections by more than one mechanism.","volume":"82","author":"Hussain","year":"2008","journal-title":"J. Virol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1039\/b916362j","article-title":"Lipid and hydrophobic modification of cationic carriers on route to superior gene vectors.","volume":"6","author":"Incani","year":"2010","journal-title":"Soft. Matter."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1016\/j.xphs.2019.03.029","article-title":"Establishment of an evaluation method for gene silencing by serial pulmonary administration of siRNA and pDNA powders: naked siRNA inhalation powder suppresses luciferase gene expression in the lung.","volume":"108","author":"Ito","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102567","article-title":"Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.","volume":"19","author":"Jamilloux","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1164\/rccm.200407-857oc","article-title":"Characterization of cytokine\/chemokine profiles of severe acute respiratory syndrome.","volume":"171","author":"Jiang","year":"2005","journal-title":"Am. J. Res. Crit Care Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"10395","DOI":"10.1128\/jvi.00748-10","article-title":"The 7a accessory protein of severe acute respiratory syndrome coronavirus acts as an RNA silencing suppressor.","volume":"84","author":"Karjee","year":"2010","journal-title":"J. Virol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jconrel.2017.04.029","article-title":"Nucleic acid combinations: a new frontier for cancer treatment.","volume":"256","author":"KC","year":"2017","journal-title":"J. Control. Rel."},{"key":"B45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4155\/tde-2019-0018","article-title":"Dry powder inhalation of siRNA.","volume":"10","author":"Keil","year":"2019","journal-title":"Ther. Deliv"},{"key":"B46","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006195","article-title":"Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication.","volume":"13","author":"Kindler","year":"2017","journal-title":"PLoS Pathog."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome.","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00109-006-0094-9","article-title":"Lessons from SARS: control of acute lung failure by the SARS receptor ACE2.","volume":"84","author":"Kuba","year":"2006","journal-title":"J. Mol. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1182\/blood-2004-10-4166","article-title":"Chemokine up-regulation in sars-coronavirus\u2013infected, monocyte-derived human dendritic cells.","volume":"106","author":"Law","year":"2005","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005466","article-title":"MAVS-mediated apoptosis and its inhibition by viral proteins.","volume":"4","author":"Lei","year":"2009","journal-title":"PLoS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/s0016-5085(03)01215-0","article-title":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection.","volume":"125","author":"Leung","year":"2003","journal-title":"Gastroenterology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"6103","DOI":"10.2147\/ijn.s112432","article-title":"Improved proliferation of antigen-specific cytolytic T lymphocytes using a multimodal nanovaccine.","volume":"11","author":"Li","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"B54","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nm1280","article-title":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque.","volume":"11","author":"Li","year":"2005","journal-title":"Nat. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/s41375-020-0848-3","article-title":"Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.","volume":"34","author":"Li","year":"2020","journal-title":"Leukemia"},{"key":"B57","article-title":"SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-\u03b21 via ROS\/p38 MAPK\/STAT3 pathway.","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.gt.3302479","article-title":"siRNA targeting the leader sequence of SARS-CoV inhibits virus replication.","volume":"12","author":"Li","year":"2005","journal-title":"Gene Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1096\/fj.06-6589com","article-title":"Spike protein of SARS-CoV stimulates cyclooxygenase-2 expression via both calcium-dependent and calcium-independent protein kinase C pathways.","volume":"21","author":"Liu","year":"2007","journal-title":"FASEB J."},{"key":"B60","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.virol.2004.03.031","article-title":"Attenuation of SARS coronavirus by a short hairpin RNA expression plasmid targeting RNA-dependent RNA polymerase.","volume":"324","author":"Lu","year":"2004","journal-title":"Virology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"12540","DOI":"10.1073\/pnas.0605402103","article-title":"Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release.","volume":"103","author":"Lu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1385\/mb:33:2:141","article-title":"Identification of effective siRNA blocking the expression of SARS viral envelope E and RDRP genes.","volume":"33","author":"Meng","year":"2006","journal-title":"Mol. Biotechnol."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.08.926006","article-title":"The insert sequence in SARS-CoV-2 enhances spike protein cleavage by TMPRSS.","author":"Meng","year":"2020","journal-title":"bioRxiv"},{"key":"B64","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.26355\/eurrev_202004_21038","article-title":"Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.","volume":"24","author":"Meo","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.actbio.2018.08.012","article-title":"Surfactant Protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy.","volume":"78","author":"Merckx","year":"2018","journal-title":"Acta Biomater."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-020-00358-y","article-title":"Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin.","volume":"19","author":"Mill\u00e1n-O\u00f1ate","year":"2020","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B67","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s40264-020-00933-4","article-title":"Chloroquine for COVID-19 infection.","volume":"43","author":"Moore","year":"2020","journal-title":"Drug Saf."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.nano.2015.01.007","article-title":"Inhalable nanoparticulate powders for respiratory delivery.","volume":"11","author":"Muralidharan","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25985","article-title":"The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.","author":"Musarrat","year":"2020","journal-title":"J. Med. Virol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","article-title":"A structural analysis of M protein in coronavirus assembly and morphology.","volume":"174","author":"Neuman","year":"2011","journal-title":"J. Struct. Biol."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-4-34","article-title":"A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection.","volume":"4","author":"Ng","year":"2004","journal-title":"BMC Infect. Dis."},{"key":"B72","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/135965350501000401","article-title":"Inhibition of replication and infection of severe acute respiratory syndrome-associated coronavirus with plasmid-mediated interference RNA.","volume":"10","author":"Ni","year":"2005","journal-title":"Antivir. Ther."},{"key":"B73","year":"2020","journal-title":"Sirnaomics to Develop RNAi"},{"key":"B74","year":"2020","journal-title":"Olix Pharmaceuticals Advances Rnai Approaches to Target Highly Conserved Regions of Coronavirus RNAS."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117956","article-title":"Vaccination strategies to combat novel corona virus SARS-CoV-2.","volume":"256","author":"Pandey","year":"2020","journal-title":"Life Sci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/annrheumdis-2020-217557","article-title":"To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.","volume":"79","author":"Parperis","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104260","article-title":"Genetic diversity and evolution of SARS-CoV-2.","volume":"81","author":"Phan","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/jclinpath-2020-206658","article-title":"Gene of the month: the 2019-nCoV\/SARS-CoV-2 novel coronavirus spike protein.","volume":"73","author":"Pillay","year":"2020","journal-title":"J. Clin. Pathol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbrc.2003.12.081","article-title":"A model of the ACE2 structure and function as a SARS-CoV receptor.","volume":"314","author":"Prabakaran","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B80","doi-asserted-by":"publisher","first-page":"10136","DOI":"10.1074\/jbc.M306124200","article-title":"Coronavirus replication complex formation utilizes components of cellular autophagy.","volume":"279","author":"Prentice","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jviromet.2007.05.017","article-title":"siRNAs targeting terminal sequences of the SARS-associated coronavirus membrane gene inhibit M protein expression through degradation of M mRNA.","volume":"145","author":"Qin","year":"2007","journal-title":"J. Virol. Methods"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.bbrc.2004.09.180","article-title":"Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells.","volume":"324","author":"Qin","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B83","first-page":"174","article-title":"SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview.","volume":"28","author":"Rabaan","year":"2020","journal-title":"Infez. Med."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-6-2","article-title":"Expression profile of immune response genes in patients with severe acute respiratory syndrome.","volume":"6","author":"Reghunathan","year":"2005","journal-title":"BMC Immunol."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-020-01291-4","article-title":"Outcomes in patients with COVID-19 infection taking ACEI\/ARB.","volume":"22","author":"Rico-Mesa","year":"2020","journal-title":"Curr. Cardiol. Rep."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2003-4-8-225","article-title":"Angiotensin-I-converting enzyme and its relatives.","volume":"4","author":"Riordan","year":"2003","journal-title":"Genome Biol."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.57278","article-title":"Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.","volume":"9","author":"Rossi","year":"2020","journal-title":"Elife"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15072","article-title":"Current pharmacological treatments for COVID-19: What\u2019s next?","author":"Scavone","year":"2020","journal-title":"Br. J. Pharmacol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"10112","DOI":"10.1128\/jvi.01001-12","article-title":"Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain.","volume":"86","author":"Schneider","year":"2012","journal-title":"J. Virol."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge.","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol. J."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.4049\/jimmunol.1303196","article-title":"SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS\/TRAF3\/TRAF6 signalosome.","volume":"193","author":"Shi","year":"2014","journal-title":"J. Immunol."},{"key":"B92","first-page":"192","article-title":"Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives \u2013 a better synergy for future COVID-19 clinical trials.","volume":"28","author":"Shittu","year":"2020","journal-title":"Infez. Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1099\/jgv.0.001047","article-title":"Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.","volume":"99","author":"Sisk","year":"2018","journal-title":"J. Gen. Virol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-59745-191-8_11","article-title":"Application of siRNA against SARS in the rhesus macaque model.","volume":"442","author":"Tang","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"B95","first-page":"714","article-title":"Potent and specific inhibition of SARS-CoV antigen expression by RNA interference.","volume":"118","author":"Tao","year":"2005","journal-title":"Chin. Med. J."},{"key":"B96","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1016\/j.vaccine.2011.05.027","article-title":"Intranasal delivery of Norwalk virus-like particles formulated in an in-situ gelling, dry powder vaccine.","volume":"29","author":"Velasquez","year":"2011","journal-title":"Vaccine"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422x-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"B98","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein.","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00298","article-title":"Subunit vaccines against emerging pathogenic human Coronaviruses.","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.1128\/jvi.78.14.7523-7527.2004","article-title":"Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells.","volume":"78","author":"Wang","year":"2004","journal-title":"J. Virol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"11116","DOI":"10.1128\/jvi.01360-15","article-title":"Genome-wide screen reveals valosin-containing protein requirement for coronavirus exit from endosomes.","volume":"89","author":"Wong","year":"2015","journal-title":"J. Virol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"B103","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1517\/13543784.15.2.89","article-title":"Antiviral applications of RNAi for coronavirus.","volume":"15","author":"Wu","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B104","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.antiviral.2004.09.005","article-title":"Inhibition of SARS-CoV replication by siRNA.","volume":"65","author":"Wu","year":"2005","journal-title":"Antiviral Res."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/v12050491","article-title":"ACE2: the key molecule for understanding the pathophysiology of severe and critical conditions of COVID-19: demon or angel?","volume":"12","author":"Xiao","year":"2020","journal-title":"Viruses"},{"key":"B106","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab.","volume":"117","author":"Xu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2106","article-title":"Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): current status, challenges, and countermeasures.","volume":"30","author":"Yan","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.7150\/ijbs.45498","article-title":"Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19.","volume":"16","author":"Yang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19.","volume":"146","author":"Yang","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2).","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis"},{"key":"B111","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/sj.cr.7290286","article-title":"Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs.","volume":"15","author":"Yi","year":"2005","journal-title":"Cell Res."},{"key":"B112","author":"Ying","year":"2006","journal-title":"Small Interfering RNA for Restraining SARS Corona Virus M Protein Gene Expression, Encoding Gene and Application Thereof"},{"key":"B113","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/21645515.2016.1239668","article-title":"Current prospects and future challenges for nasal vaccine delivery.","volume":"13","author":"Yusuf","year":"2017","journal-title":"Hum. Vac. Immunother."},{"key":"B114","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.","volume":"46","author":"Zhang","year":"","journal-title":"Intensive Care Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1164\/rccm.202003-0541OC","article-title":"Expression of the SARS-CoV-2 ACE2 receptor in the human airway epithelium.","volume":"202","author":"Zhang","year":"","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.bbamem.2013.07.025","article-title":"The ORF4a protein of human coronavirus 229E functions as a viroporin that regulates viral production.","volume":"1838","author":"Zhang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B117","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0014-5793(04)00087-0","article-title":"Silencing SARS-CoV spike protein expression in cultured cells by RNA interference.","volume":"560","author":"Zhang","year":"2004","journal-title":"FEBS Lett."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway memory CD4+ T cells mediate protective immunity against emerging respiratory coronaviruses.","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/j.febslet.2005.02.080","article-title":"Small interfering RNA inhibits SARS-CoV nucleocapsid gene expression in cultured cells and mouse muscles.","volume":"579","author":"Zhao","year":"2005","journal-title":"FEBS Lett."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis.","author":"Zheng","year":"2020","journal-title":"J. Infect"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/jac\/dkaa114","article-title":"COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.","volume":"75","author":"Zhou","year":"2020","journal-title":"J. Antimicrob. Chemother"},{"key":"B122","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00011-009-8062-9","article-title":"Differential characteristics of the early stage of lung inflammation induced by SARS-CoV Nucleocapsid protein related to age in the mouse.","volume":"58","author":"Zhu","year":"2009","journal-title":"Inflam. Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ijid.2020.04.041","article-title":"Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019.","volume":"95","author":"Zhu","year":"2020","journal-title":"Int. J. Infect. Dis."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fbioe.2020.00916\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T05:26:53Z","timestamp":1667626013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fbioe.2020.00916\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":123,"alternative-id":["10.3389\/fbioe.2020.00916"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2020.00916","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,30]]},"article-number":"916"}}